Antibody-drug conjugates (ADCs) represent a promising advancement in the battle with cancer. ADCs integrate the precision of antibodies with the potent power of cytotoxic drugs. By delivering these potent agents directly to cancer cells, ADCs maximize treatment efficacy while minimizing harm to heal